![Pierre Gerard Cassigneul](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pierre Gerard Cassigneul
Director/Board Member at Enterome SA
Network origin in Pierre Gerard Cassigneul first degree
Entity | Entity type | Industry | |
---|---|---|---|
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Public Company | Medical Specialties | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pierre Gerard Cassigneul via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Iconic Therapeutics, Inc.
![]() Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
NATUREX | Food: Specialty/Candy | Director/Board Member | |
Laboratoires Fournier SAS
![]() Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arthur Andersen LLP
![]() Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fournier Pharma SA
![]() Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Fournier Pharma SA manufactures pharmaceutical products. The firm is also in the engaged in the research, development, production and marketing of molecules. The company has operations in Canada, China, Algeria, Bulgaria, Thailand and Turkey. It was founded in 1880 and is headquartered in Chenôve, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ethypharm SAS
![]() Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member Founder | |
Polaris SA /FR/
![]() Polaris SA /FR/ Pharmaceuticals: MajorHealth Technology Polaris SA engages in the biotechnology industry and specializes in the field of healthy omega 3 lipids. The company was founded by St?phane Lozachmeur and Gildas Breton on July 1, 1994 and is headquartered in Quimper, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
Iome Bio SA
![]() Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | Pharmaceuticals: Other | Director/Board Member | |
A-Mansia Biotech SA (Belgium)
![]() A-Mansia Biotech SA (Belgium) Miscellaneous Commercial ServicesCommercial Services A-Mansia Biotech provides business services. The company was founded on October 11, 2016 and is headquartered in Ottignies-Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
LiMM Therapeutics SA
![]() LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member | |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
YSOPIA Biosciences SA
![]() YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Director/Board Member | |
BIOPHYTIS S.A. | Pharmaceuticals: Other | Director/Board Member | |
IO BIOTECH, INC. | Biotechnology | Chairman | |
VAXCYTE, INC. | Biotechnology | Director/Board Member | |
IO Biotech ApS
![]() IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman | |
Escient Pharmaceuticals, Inc.
![]() Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
TRex Bio Ltd.
![]() TRex Bio Ltd. BiotechnologyHealth Technology TRex Bio Ltd. is a British company that provides biotechnology research and development services. The private company is based in London, UK. The company was founded in 2018 by Houman Ashrafian. | Biotechnology | Director/Board Member | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Chief Executive Officer | |
Sanofi-Aventis France SA
![]() Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Medical Distributors | Corporate Officer/Principal | |
Vivostat A/S
![]() Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Medical Specialties | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree | |
Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Pharmaceuticals: Major | Corporate Officer/Principal | |
ILTOO Pharma SAS
![]() ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | Miscellaneous Commercial Services | Director/Board Member | |
University of Copenhagen | College/University | Graduate Degree | |
Varmx BV
![]() Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Xyence Capital SGR
![]() Xyence Capital SGR Investment ManagersFinance Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy. | Investment Managers | Chief Executive Officer | |
Lio Capital Srl
![]() Lio Capital Srl Financial ConglomeratesFinance Lio Capital Srl engages in the provision of investment services. It specializes in special situations and distressed investments. Its activities include purchase of overdue credits from small and medium-sized enterprises (SMEs) operating in the Italian Public Administration sector, selection of distressed mortgage loans, and purchase of mortgage loans at a discount, but lower than the current market value of the collateral. The company was founded in 2012 and is headquartered in Milan, Italy. | Financial Conglomerates | Private Equity Investor | |
Definitive Capital Management LP
![]() Definitive Capital Management LP Investment ManagersFinance Founded in 2010, Definitive Capital Management LP is a hedge fund manager located in Radnor, Pennsylvania. The firm manages the Definitive Guardian Fund Ltd. (formerly the Vision Guardian Fund Ltd.) and the Definitive Guardian Partners LP (formerly the Vision Guardian Partners LP). | Investment Managers | Portfolio Manager-Equities | |
Acesion Pharma ApS
![]() Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
GLOBAL FASHION GROUP S.A. | Apparel/Footwear Retail | Corporate Officer/Principal |
Statistics
International
France | 21 |
United States | 12 |
Denmark | 7 |
Italy | 3 |
Belgium | 2 |
Sectoral
Health Technology | 29 |
Finance | 6 |
Commercial Services | 5 |
Consumer Services | 5 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 66 |
Corporate Officer/Principal | 42 |
Independent Dir/Board Member | 19 |
Chairman | 18 |
Chief Executive Officer | 10 |
Most connected contacts
Insiders | |
---|---|
Georges Gemayel | 33 |
Isabelle de Cremoux | 21 |
K. Hirth | 18 |
Mary Thistle | 16 |
Luca Marini | 14 |
Pierre Marc Bélichard | 10 |
Gavin A. Bell | 8 |
Roger Garceau | 8 |
Mark Throdahl | 8 |
Lars Gredsted | 7 |
Nancy Lelicoff | 6 |
Girindre Beeharry | 5 |
Stephanie McCune | 4 |
Marie-Laure Bouttier | 4 |
Kenneth Kassler-Taub | 4 |
- Stock Market
- Insiders
- Pierre Gerard Cassigneul
- Company connections